Similar Articles
331 Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics
332 Hepatocellular carcinoma: State of the art diagnostic imaging
333 Pain management in patients with hepatocellular carcinoma after transcatheter arterial chemoembolisation: A retrospective study
334 Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience
335 Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations
336 Possible mechanisms associated with immune escape and apoptosis on anti-hepatocellular carcinoma effect of Mu Ji Fang granules
337 Systemic treatment for unresectable hepatocellular carcinoma
338 Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma
339 Predictors of early and late hepatocellular carcinoma recurrence
340 Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubin
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA